BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 130240)

  • 1. Methotrexate inhibition of CCRF-CEM cultures of human lymphoblasts.
    Roberts D; Warmath EV
    Eur J Cancer (1965); 1975 Nov; 11(11):771-82. PubMed ID: 130240
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential calcium leucovorin protection of human lymphoid cell lines from methotrexate.
    Browman GP; Booker L; Spiegl P
    Cancer Chemother Pharmacol; 1985; 15(2):105-10. PubMed ID: 2410158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of action of methotrexate in cultured L5178Y leukemia cells.
    Hryniuk WM
    Cancer Res; 1975 Apr; 35(4):1085-92. PubMed ID: 1054288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the deoxyribonucleoside triphosphate pools of mouse 5178Y lymphoma cells following exposure to methotrexate or 5-fluorouracil.
    Tattersall MH; Harrap KR
    Cancer Res; 1973 Dec; 33(12):3086-90. PubMed ID: 4543390
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
    Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
    Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of thymidylate synthetase activity in CCRF-CEM cells.
    Roberts D; Loehr EV
    Cancer Res; 1971 Sep; 31(9):1181-7. PubMed ID: 5315660
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
    Mini E; Moroson BA; Bertino JR
    Cancer Treat Rep; 1987 Apr; 71(4):381-9. PubMed ID: 2950995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel pyrrolo[2,3-d]pyrimidine antifolate TNP-351: cytotoxic effect on methotrexate-resistant CCRF-CEM cells and inhibition of transformylases of de novo purine biosynthesis.
    Itoh F; Russello O; Akimoto H; Beardsley GP
    Cancer Chemother Pharmacol; 1994; 34(4):273-9. PubMed ID: 8033293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the poor correlation between the inhibition by methotrexate of dihydrofolate reductase and of deoxynucleoside incorporation into DNA.
    Roberts D; Wodinsky I
    Cancer Res; 1968 Oct; 28(10):1955-62. PubMed ID: 5696929
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the effects of methotrexate and pyrimethamine on L5178Y lymphoblasts in cell culture.
    Goldie JH; Furness ME; Price LA
    Eur J Cancer (1965); 1973 Oct; 9(10):709-15. PubMed ID: 4529729
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of methotrexate on deoxyribonucleotide pools and DNA synthesis in human lymphocytic cells.
    Fridland A
    Cancer Res; 1974 Aug; 34(8):1883-8. PubMed ID: 4526300
    [No Abstract]   [Full Text] [Related]  

  • 12. The intracellular mechanism of action of metoprine (DDMP).
    Browman GP; Calvert AH; Taylor GA; Hart LI; Harrap KR
    Eur J Cancer (1965); 1980 Dec; 16(12):1547-54. PubMed ID: 6971755
    [No Abstract]   [Full Text] [Related]  

  • 13. Consequences of methotrexate inhibition of purine biosynthesis in L5178Y cells.
    Hryniuk WM; Brox LW; Henderson JF; Tamaoki T
    Cancer Res; 1975 Jun; 35(6):1427-32. PubMed ID: 1055632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical correlates of in vitro effect of methotrexate on acute leukemia blasts.
    Hryniuk WM; Bishop A; Foerster J
    Cancer Res; 1974 Oct; 34(10):2823-9. PubMed ID: 4547159
    [No Abstract]   [Full Text] [Related]  

  • 15. The response in vitro, of continuous cultures of human lymphoblasts (CCRF-CEM cells) to chemotherapeutic agents.
    Foley GE; Lazarus H
    Biochem Pharmacol; 1967 Apr; 16(4):659-74. PubMed ID: 4226738
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies relating to the mode of action of methotrexate. II. Studies on sites of action in L-cells in vitro.
    Borsa J; Whitmore GF
    Mol Pharmacol; 1969 Jul; 5(4):303-17. PubMed ID: 5306609
    [No Abstract]   [Full Text] [Related]  

  • 17. New dose-time relationships of folate antagonists to sustain inhibition of human lymphoblasts and leukemic cells in vitro.
    Sedwick WD; Kutler M; Frazer T; Brown OE; Laszlo J
    Cancer Res; 1979 Sep; 39(9):3612-8. PubMed ID: 314333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of thymidine-resistant cells from a thymidine-sensitive acute lymphoblastic leukemia cell line.
    Zielke HR
    Cancer Res; 1979 Sep; 39(9):3373-6. PubMed ID: 289439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines.
    Mini E; Moroson BA; Franco CT; Bertino JR
    Cancer Res; 1985 Jan; 45(1):325-30. PubMed ID: 3855284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinazoline antifolates as inhibitors of dihydrofolate reductase from human leukemia cells.
    Johns DG; Capizzi RL; Nahas A; Cashmore AR; Bertino JR
    Biochem Pharmacol; 1970 Apr; 19(4):1528-33. PubMed ID: 5284463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.